# Synthetica Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/synthetica-bio

- Industry: Healthcare IT
- Headquarters: Laguna Beach, US
- Website: www.syntheticabio.ai
- Total disclosed funding: $1.3M
- Latest round: Seed (Jun 5, 2023)
- Investors on record: 3

## About

Based in California, US, and founded in 2023, Synthetica Bio, Inc operates as a health technology company that develops generative artificial intelligence products for the biopharmaceutical industry. The company was founded by Simon Arkell (CEO) and Alex Dickinson. In June 2023, Synthetica Bio, Inc. raised USD 1.33 million in seed funding led by Virtue Venture Management, AIX Ventures, and PageOne.vc.

The company develops a generative artificial intelligence platform that helps clinical and commercial teams. The platform provides its clients with complex data using generative artificial intelligence technology. The users can access real-time data streams for biopharmaceutical applications.

The company develops a generative artificial intelligence platform that helps clinical and commercial teams. The platform provides its clients with complex data using generative artificial intelligence technology. The users can access real-time data streams for biopharmaceutical applications.

The company plans to use the June 2023 funding to advance the development and expansion of its generative AI platform for the biopharmaceutical industry.

## Funding rounds

- Seed, Jun 5, 2023, $1.3M — AIX Ventures, Page One Ventures, Virtue Venture Management

## Investors

- AIX Ventures (https://capitalatlas.ai/funds/aix-ventures) — Seed
- Page One Ventures (https://capitalatlas.ai/funds/page-one-ventures) — Seed
- Virtue Venture Management (https://capitalatlas.ai/funds/virtue-venture-management) — Seed